- Home
- Companies
- north america
- rhinitis
Show results for
Refine by
Rhinitis Suppliers In North America
13 companies found
based inSunnyvale, CALIFORNIA (USA)
At Aerin Medical, our mission is to provide ENTs with advanced treatment options for chronic nasal conditions that positively affect the quality of life of millions of patients. We believe that patients deserve the freedom to breathe better and live ...
For many patients struggling with chronic rhinitis, medical management does not provide the long-lasting relief they seek, and they remain tied to tissues and sprays to cope with their daily ...
based inPlattsburgh, NEW YORK (USA)
NasoNeb® Nasal Delivery Systems (NDS), now a division of Monaghan Medical Corporation, is a global developer and manufacturer of intranasal drug delivery systems inspired by ENT clinics and designed with healthcare specialists in mind. The flagship ...
based inShirley, NEW YORK (USA)
Creative Enzymes uses its expertise in enzyme manufacturing to supply customers enzymes using for life science research and production of medicines, food, alcohol, beer, fruit juice, fabric, paper, leather goods, etc. Our products are used worldwide ...
Chymotrypsin is a digestive enzyme component of pancreatic juice acting in the duodenum where it performs proteolysis, the breakdown of proteins and polypeptides. Chymotrypsin preferentially cleaves peptide amide bonds where the carboxyl side of the ...
based inSarasota, FLORIDA (USA)
Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and ...
FebriDx is a rapid, all-in-one point-of-care test device that can differentiate a viral from bacterial acute respiratory infection. FebriDx® can be used to help triage patients at the point of care to reduce uncertainty and avoid unnecessary ...
based inOranmore, IRELAND
Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. The privately held, venture backed company is based in Galway Ireland. Neurent Medical was founded by CEO ...
The NEUROMARK System is designed to treat symptoms of chronic rhinitis safely and effectively in the ENT physician’s office with a high degree of patient comfort. The system is engineered to gently apply controlled low-power ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Bakuchiol is a phytoestrogen that can be obtained from psoralen seeds. Bakuchiol has been proven to be a non-competitive inhibitor of multiple enzymes, including UDP-glucuronosyltransferase 2B7 (UGT2B7) [2] and human carboxylesterase 2 (hCE2) [3], ...
based inStockholm, SWEDEN
NoseOption AB is a MedTech company manufacturing and selling nasal breathing devices. With a vision to create a better breathing experience for everyone, NoseOption offers a unique portfolio of nasal devices that filters out odor, allergens, smog, ...
NOSA allergy filter is a nasal filter that seals tight, is easy to breathe through and efficiently filters harmful airborne particles such as pollen, pet dander, dust, and ...
based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Animal models have been making remarkable contributions to the understanding of genetics and immune-mediated pathophysiology of allergic rhinitis. Non-human primates (NHPs) exhibit plenty of similarities with humans in terms of ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
Atopic Dermatitis (AD) is prevalent among children aged 1 to 5 years and a considerable number of patients carry this condition into adulthood. As a chronic inflammatory skin disease, AD often coexists with asthma and rhinitis. At ...
based inFayette, MISSOURI (USA)
Addison Biological Laboratory, Inc. is a Fayette, MO based manufacturer and marketer of exclusive veterinary technologies. For over a third of a century, J. Bruce Addison, president and founder, has been recognized as a leader in veterinary ...
MAXI/GUARD® Nasal Vac® – An avirulent live culture Bordetella bronchiseptica vaccine for the prevention of respiratory disease in baby pigs. MAXI/GUARD Nasal Vac features include one dose intranasal administration, providing benefits ...
based inCambridge, MASSACHUSETTS (USA)
AOBiome has identified significant therapeutic opportunities caused by the adverse impact of the modern environment on human physiology. The human body relies on a system of multiple microorganisms, chemistries, and pathways which have shaped the ...
The human microbiome consists of hundreds of trillions of microorganisms, outnumbering human cells by 10 to 1 with as many as 3 million bacterial genes to our approximately 20 thousand. While the microbiome has recently become an area of active ...
based inBasel, SWITZERLAND
We at Auris Medical are a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. We are focusing on the development of intranasal betahistine ...
Development of Bentrio™ (AM-301) has been completed. The product has been introduced to the market, starting in selected countries of the European ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...